INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, cilt.9, sa.5, ss.725-729, 2016 (SCI-Expanded)
AIM: To evaluate central macular thickness (CMT) and mean choroidal thickness (MCT) in eyes with branch retinal vein occlusion (BRVO), before and after ranibizumab treatment using spectral domain -optical coherence tomography (SD-OCT).